Sumanasham Pharma Private Limited
About Sumanasham Pharma Private Limited
Data last updated:
Sumanasham Pharma Private Limited is a private limited company based in Badangpet, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2019PTC138061. Its GSTIN is 36ABDCS1687E1Z9 (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Palla Naresh and Palla Uma Maheshwar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No 13 – 25/93 Steert No 04 Sri Vidya Towenship Near Tirumala Garden, Badangpet, Telangana, India – 500058.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.27 Lakh, a growth of 72% compared to the previous year. For the same year it recorded a net profit of ₹70,753 (net margin 4.1%) and EBITDA of ₹1.13 Lakh (EBITDA margin 6.6%). Revenue has grown at a compounded annual rate (CAGR) of 176% over three years.
Company details
Contact details
Sumanasham Pharma Private Limited's registered office is in Badangpet, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No 13 – 25/93 Steert No 04 Sri Vidya Towenship Near Tirumala Garden, Badangpet, Telangana, India – 500058
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sumanasham Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sumanasham Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sumanasham Pharma Private Limited, buy the company report.
Financials of Sumanasham Pharma Private Limited
FY 2025 filings availableSumanasham Pharma Private Limited reported revenue of ₹17.27 Lakh (up 72% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 176% over three years, including 72% growth in the latest year. EBITDA rose 93% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.13 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹70,753 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.6% | ||||
| Net Profit Margin | 4.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sumanasham Pharma Private Limited, buy the company report.
Board of directors of Sumanasham Pharma Private Limited
Sumanasham Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Palla Naresh | Director | 31 Dec 2019 | 6 Years 9 Months | Current |
| Palla Uma Maheshwar | Director | 31 Dec 2019 | 6 Years 9 Months | Current |
Peer comparison
Sumanasham Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| BK and BS Enterprises Private Limited | ₹17.34 Lakh (FY 2024) | -48.0% | Hyderabad, Telangana, India | |||
| Unicordis Pharma India Private Limited | ₹17.34 Lakh (FY 2016) | -2.0% | Salem, Tamil Nadu, India | |||
| Shashank Medi Pharma Private Limited | ₹17.33 Lakh (FY 2020) | -55.0% | Lucknow, Uttar Pradesh, India | |||
| Natchura Pharma Limited | ₹17.29 Lakh (FY 2025) | 13.0% | Salem, Tamil Nadu, India | |||
| Sumanasham Pharma Private Limitedthis company | ₹17.27 Lakh (FY 2024) | ₹70,753 | 4.1% | 72.0% | Badangpet, Telangana, India | |
| Biospace Medical System Private Limited | ₹17.25 Lakh (FY 2019) | -46.0% | Patna, Bihar, India |
To see the full peer comparison of Sumanasham Pharma Private Limited, buy the company report.
Auditor
Sumanasham Pharma Private Limited is audited by G.RAJENDRA PRASAD for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G.RAJENDRA PRASAD | FY 2023 | 232511 |
Shareholding
The shareholding of Sumanasham Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Sumanasham Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sumanasham Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sumanasham Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sumanasham Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABDCS1687E1Z9 | Telangana | Active | 08 Jan 2020 |
To see the full GST registrations and return filing status of Sumanasham Pharma Private Limited, buy the company report.
Recent activity
Sumanasham Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Palla Naresh was appointed as Director on 31 Dec 2019.
Frequently asked questions
Sumanasham Pharma is an active private limited company based in Badangpet, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 December 2019 (7+ years old) and is registered under CIN U24100TG2019PTC138061.
Sumanasham Pharma has 2 current directors:
- Palla Naresh - Director
- Palla Uma Maheshwar - Director
The latest financial statements of Sumanasham Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Sumanasham Pharma is 36ABDCS1687E1Z9, registered in Telangana.
The CIN (Corporate Identification Number) of Sumanasham Pharma is U24100TG2019PTC138061. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sumanasham Pharma was incorporated on 31 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sumanasham Pharma by revenue are BK and BS Enterprises Private Limited, Unicordis Pharma India Private Limited, Shashank Medi Pharma Private Limited, Natchura Pharma Limited, Biospace Medical System Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Palla Naresh was appointed as Director on 31 Dec 2019. Palla Uma Maheshwar was appointed as Director on 31 Dec 2019.
The registered office of Sumanasham Pharma is at H.No 13 – 2593 Steert No 04 Sri Vidya Towenship Near Tirumala Garden, Badangpet, Telangana, India – 500058.
Sumanasham Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sumanasham Pharma can be reached at its registered office: H.No 13 – 2593 Steert No 04 Sri Vidya Towenship Near Tirumala Garden, Badangpet, Telangana, India – 500058.